Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: AIChE J. 2021 Oct 4;67(12):e17485. doi: 10.1002/aic.17485

Response of Astrocytes to Blood Exposure due to Shunt Insertion in vitro

Mira Zaranek 1, Rooshan Arshad 1, Kevin Zheng 1, Carolyn A Harris 1
PMCID: PMC9049769  NIHMSID: NIHMS1745587  PMID: 35497642

Abstract

The breakdown of the ventricular zone (VZ) with the presence of blood in cerebrospinal fluid (CSF) has been shown to increase shunt catheter obstruction in the treatment of hydrocephalus, but the mechanisms by which this occurs are generally unknown. Using a custom-built incubation chamber, we immunofluorescently assayed cell attachment and morphology on shunt catheters with and without blood after 14 days. Samples exposed to blood showed significantly increased cell attachment (average total cell count 392.0±317.1 versus control of 94.7±44.5, P<0.0001). Analysis of the glial fibrillary acidic protein (GFAP) expression showed similar trends (854.4±450.7 versus control of 174.3±116.5, P<0.0001). An in vitro model was developed to represent the exposure of astrocytes to blood following an increase in BBB permeability. Exposure of astrocytes to blood increases the number of cells and their spread on the shunt.

Keywords: Ventricular Catheter, Posthemorrhagic Hydrocephalus, Blood Brain Barrier, Hemorrhage

Introduction

The condition hydrocephalus can be distinguished as the dilation of the cerebral ventricles due to an excessive accumulation of cerebrospinal fluid (CSF)14. This fluid buildup can be caused by an imbalance between the production and absorption of the CSF within the brain with the root variable etiology, including precursors such as hemorrhage, congenital malformations, and tumors1,2,5. Treatment typically involves the insertion of a shunt system, including a shunt catheter into the brain’s ventricular space to drain excess CSF6. Shunt failure is one of the highest among all neurological devices with 40–50% requiring revision within the first two years and 80% within 10 years7,8. Obstruction of the ventricular catheter accounts for 70% of shunt failures, which makes it the most prevalent failure modality compared to infection, over-drainage, and loculated ventricles6. The dominant cell types involved in the blocking of these holes are astrocytes and cells of the monocyte-macrophage lineage, suspected to be due to inflammatory stimuli6,9,10.

Blood can enter the ventricle in two ways, intraventricular hemorrhages along with breaking of the blood brain barrier at the time of shunt insertion11,12. Posthemorrhagic hydrocephalus (PHH), one of the most common forms of hydrocephalus, is a result of an intraventricular hemorrhage (IVH)13. These patients make up the largest percentage of shunt failures caused by obstruction of the proximal holes14. For neonates born prematurely, 20% develop an IVH and 50% of those individuals progress into PHH12. In addition to etiology, blood brain barrier (BBB) breakdown from shunt insertion can play a major role in the CSF blood content10,15,16. Initial insertion of the ventricular catheter can cause hemorrhages and edema in the ventricular space11. Edema reaches a maximum at day one post-surgery while healing of the BBB insult can take two to three weeks resulting in further exposure of the VZ to blood products11,15,17. Disruption of the VZ, following blood exposure, is a result of an overall loss of ependymal cells allowing for increased CSF accumulation and prolonged inflammation18. Ependymal cell loss can be attributed to cell junction dislocation and neural stem cell (NSC) differentiation impairment creating denuded areas for astrocyte exposure to the blood products12,19. The introduction of blood into the CSF, resulting in the disruption of cells of the ventricular zone (VZ) that leads to increased dilation and permeability of the ventricle2,12.

An inflammatory response occurs within the ventricles following the infiltration of blood, which stimulates the activation of astrocytes and microglia10,20. This astrocyte and microglia activation is maintained for up to 28 days post shunt insertion21. Glial activation is a result of various cytokines and growth factors produced by the activated microglia and leads to the rapid proliferation of astrocytes2123. In response to this activation, an astrocyte layer is created to cover the denuded areas, from loss of ependymal cells, which was shown to increase cellular migration and attachment to the shunt surface20,24. Blood within the CSF has been shown, in vivo, to cause an increase in shunt obstruction causing failure making up 34.8% of shunt revisions25. It has been theorized that the loss of VZ integrity allows for a higher infiltration of astrocytes into the ventricular zone by astrogliosis12.

The current study aims to investigate the impact of whole blood exposure on mouse astrocyte cells and its direct influence on ventricular shunt catheter obstruction. In this way, we examine the role blood plays on the foreign body response to chronic indwelling shunt catheters. Other studies have shown that the disruption of ependymal layer in the VZ allows for the activation of astrocytes resulting in the infiltration into the ventricular space26. In this study an in vitro model has been developed to mimic the introduction of blood to the CSF by breaking of the BBB following catheter insertion and the response of astrocytes to this stimulus is evaluated. This 3D model can be applied in various tests to allow for a catheter to be exposed to various stimuli in static culture. We hypothesize that the activation of astrocytes will occur when exposed to blood over a two-week period, representing the healing time of the permeable BBB, and result in an increase of cellular attachment to the surface of the catheter.

Methods and Materials

Shunt Creation

Medical grade barium-impregnated silicone catheter tubing with an outer diameter of 2.8 mm and inner diameter of 1.5 mm (Medtronic, Minneapolis, MN) were cut into 2-centimeter segments. To mimic the conical shape of hole in industrial made catheters, eight holes were punched using a 0.5 mm diameter leather punch 1.25 mm apart. Dimension used followed those seen in Medtronic catheters. The catheter was rotated 90 degrees, two times, repeating the punching process to create a total of three rows of eight holes. Excess catheter material left over after punching the holes was removed using tweezers. The final dimensions of the catheter holes were 0.5 mm outer diameter with 1 mm edge to edge separation, confirmed with confocal microscopy (Figure 5). The outer diameter was measured to ensure this method resulted in accurate dimensions after manually punching the samples. Sterilization of these samples began with a one-hour incubation in 10% bleach. Following this, a series of washes included a 30-minute incubation in ethanol followed by two 10-minute washes with double distilled cell culture water (Growcells, Irvine, CA). Phenol red (v/v 1%) (Sigma, St. Louis, MO) was added into the last wash to observe if a color change occurred, ensuring all ethanol was removed.

Figure 5:

Figure 5:

Representative images of the catheter with DAPI and GFAP as blue and green shading respectively. The portions of the catheter in green represent the GFAP stain and the cytoplasm of the astrocyte, and the parts in blue represent the nuclei of the cells. These images show a representation of staining expression on the surface of the catheter. In the blood exposed sample, in (C), an over expression of GFAP was observed, seen in green. (A) Control Sample - Side Row of Holes (B) Blood Exposed Sample – Side Row of Holes (C) Control Sample – Rows of Holes in Direct Contact with Cells (D) Blood Exposed Sample – Rows of Holes in Direct Contact with Cells. Scale bar indicates 1000 μm.

Novel Blood Contact Model System, Glass Coverslip Coating, and Sterilization

Creation of the resin 3D-printed chambers utilized Autodesk’s Fusion 360 and Photon Workshop V2.1.24 software to design and slice the model for printing. Set up of the ANYCUBIC Photon S SLA 3D resin printer required the leveling of the build plate and vigorous shaking of the Sculpt High Temperature Resin from Siraya Tech for five minutes. Approximately 150 mL of resin was poured into the resin vat before beginning the print.

Once printing was completed, the chambers were left to soak in ethanol overnight. The next day, the chambers were hand dried and placed into a dehydrator for 30 minutes to remove excess ethanol. During the last five minutes of drying the chambers, a glass container was filled with enough water to fully submerge the print. The water was heated until it was warm to the touch. Once the drying process concluded, the chambers were exposed to UV light on all sides in two 15-minute increments for a total of 30 minutes, completely curing the prints.

After curing, the prints were placed back into the dehydrator for 30 minutes to remove the excess volatile organic compounds (VOCs) within the resin. A glass coverslip (Thomas Scientific, Swedesboro, NJ) was added into each well as the substrate to seed the cells onto. The glass coverslip was bound to the base of the well using Loctite Clear Silicone Waterproof Sealant and Loctite Professional Super Glue placed with an 18-gauge needle. Finally, the chamber was dehydrated for a final 15 minutes to completely remove any excess VOCs left after the addition of glue.

Sterilization of the chambers was done by soaking them in 70% (w/v) ethanol for 30 minutes followed by two 10-minute washes with double distilled water (Growcells, Irvine, CA). Before seeding the cells on the glass coverslip, the chambers were coated with 500 μL of a 50 μg/mL poly-D-lysine solution overnight with phenol red (v/v 1%). The next morning, glass coverslips were rinsed with 500 μL of double distilled water containing phenol red (v/v 1%) (Sigma, St. Louis, MO) and left to dry for two hours before seeding.

pH Tests

During the sterilization process, washes with double distilled water with 1% (v/v) phenol red was used to observe color changes to ensure the ethanol was effectively removed. Insignificant color change showed that the majority of the ethanol was removed. Following sterilization, the glass coverslips were coated with poly-D-lysine with phenol red added overnight, and the next morning no color change was observed. The addition of 1.86 g of sodium bicarbonate was supplemented into the media to balance the pH within the system.

Blood Extraction and Storage

Blood storage buffer was created using the standard concentrations for the citrate-phosphate-dextrose with the addition of adenine (CPDA-1) buffer. On top of the CPDA-1 buffer, additive solution three (AS-3) was combined with the blood to provide extra nutrients27. Briefly, a mixture of sodium citrate tribasic dehydrate, citric acid, dextrose, adenine, sodium phosphate monobasic, and sodium chloride were dissolved in double distilled water to create the buffer solution (Sigma, St. Louis, MO). Due to the small volume of buffer required, the reagents were massed and dissolved in 1000 μL of double distilled water. The necessary volume of the reagent was then combined and brought to 5 mL with excess double distilled water.

All animal protocols were approved by the Wayne State University Institution of Animal Care and Use Committee (IACUC). Extraction of blood from a C57BL/6 male mice was performed using a full body massage, similar to a retro-orbital massage, technique following euthanasia via carbon dioxide and consequent decapitation. Microcentrifuge tubes, filled with 122.8 μL of citrate buffer, were used to collect the blood. Each tube was filled with 877.2 μL of blood to obtain a 1 mL final volume. After extraction, the blood was immediately placed on ice until added to the cell culture media. For long term storage, the tubes of blood were kept at 4°C.

Cell Culturing and Catheter Insertion

Mouse primary astrocytes, Type III clone from the brain and cerebellum, were used for these experiments (ATCC C8-D30). The recommended cell culture media (ATCC) was a mixture of Dulbecco’s Modified Eagle’s Medium (DMEM) with supplemental 50 mL of fetal bovine serum. The addition of 5 mL of penicillin-streptomycin solution was also added into the media. Stabilization of the pH within the culture was accomplished by adding 1.86 grams of sodium bicarbonate was added into the media. Cells were allowed to grow in vented T75 Tissue Culture Treated Flasks (Falcon) for two weeks with media changes every three days. Cell removal was done using 2 mL of Trypsin-EDTA (v/v 0.25%) with phenol red (Gibco, Waltham, MA) incubated at 37°C with a CO2 level of 5% for five minutes. Following the incubation, 4 mL of media was added into the flask to assist with cell dislodgement and stop the enzymatic activity of the trypsin. The cells were collected in a 15 mL falcon tube and centrifuged at 125 G for seven minutes. After centrifugation, the supernatant was removed, and 1 mL of media was added to homogenize the cells.

Using a 50% (v/v) trypan blue (Gibco, Waltham, MA) concentration, the cells were counted using a hemacytometer, and the cells were brought to a concentration of one million cells per 1 mL of media. They were then seeded by pipetting a 100 μL drop of the cell and media mixture on the center of the glass coverslip. This droplet of cells was left for one hour in a 37°C incubator with a 5% CO2 concentration to allow for the cells to attach on the coverslip. Afterwards, an additional 1000 μL of media was added to the culture. A media change was done after 24 hours and then changed every three days.

These cells were allowed to grow for one week before of the 20 mm catheter samples were added into the chamber. Using tweezers, the sterilized catheter segments were placed into two indentations on either side of the well. A mark was made on the side of the catheter without holes to position the sample. The three rows of holes punched into the catheter were oriented with the middle set of holes in direct contact with the cell layer. Labeling of the row of holes was done based on their orientation within the chamber.

At the same time as catheter insertion, the blood was added into the media. A concentration of 15 μL of blood per 1 mL of media was used. This concentration of blood followed the rationale tested in experiments performed by Castaneyra-Ruiz12,28. In a separate microcentrifuge tube, 100 μL of blood was mixed with CaCl2 (Sigma, St. Louis, MO) to obtain a final concentration of 20 mM concentration to reverse the anticoagulation. This solution was then homogenized and added into 5 mL of media. In the blood exposed samples, 1000 μL of the blood and media mixture was pipetted in the each well. The control group used the same chamber system, and the catheter was inserted in the same fashion as described above for the sample with blood. The media used for the control samples was the same as the blood exposed samples without the addition of blood. Media was changed every three days by exchanging spent media with 1000 μL fresh media.

Staining

Samples ran for a total of two weeks before fixing them with two washes of 0.01 M phosphate buffer solution (PBS) (Sigma, St. Louis, MO). The volume used for the following solutions was 500 μL per sample, except for PBS washes which were at 1000 μL. The cells were then exposed to a 4% paraformaldehyde (Sigma, St. Louis, MO) solution for seven minutes, followed by two rinses with a 0.01 M PBS. Permeabilization of the cells was done by incubating them in sodium borohydride (Sigma, St. Louis, MO) and a citrate buffer (Sigma, St. Louis, MO) for 30 minutes each. The citrate buffer was heated to 100°C before adding it on the samples, and then heated at 80°C during the incubation period. Samples were then incubated in BlockAid blocking solution (ThermoFisher, Waltham, MA) for 30 minutes.

Staining the astrocytes was done by using the primary antibody glial fibrillary acidic protein (GFAP) Polyclonal Antibody (ThermoFisher PA1-10004) and the secondary antibody Goat anti-Chicken IgY 555 ThermoFisher A-21437) for 24 hours each. GFAP was used here to identify cell count, but more importantly cell spread and degree of activation. The antibodies were diluted, using 0.4% Triton solution in 0.01 M PBS, to 1:1000 for the primaries and 5:1000 for the secondaries. After incubating the samples with the secondary antibodies, the samples were washed with 0.01 M PBS. The nuclei were stained using the DAPI Solution (ThermoFisher, Product No.62248) with a 1:1000 ratio in 0.01 M PBS for 30 minutes.

Imaging and Analysis

Before imaging, the top portion of the chamber was broken off to allow imaging. Using a Caliber I.D. RS-G4 Ribbon Scanning Confocal microscope with lasers set to 405 and 561 wavelength, images of the catheter were taken from above still in the chamber. Images were taken, once the catheter was removed, for the row of holes in direct contact with the cells. Analysis of these 3D images was done using Imaris software to obtain cell counts of each of the three sets of eight holes. Images taken from above the catheter while still in the chamber were taken to count the cells around the sides of the catheter. The image of the row of holes that came into direct contact with the cells were counted using the image taken below the catheter after removal. Counts for DAPI and GFAP were taken individually with a consistent volume. A box was positioned to obtain a cell count around the holes. The holes along the side of the sample used the box dimensions 1800×17000×125 and 2000×17000×75 around the holes in direct contact with the cells.

Statistical Analysis

Analysis of the data consisted for cell counts along the side rows of holes and the bottom row of holes. The control group and blood exposed group each had a n=5 of replicates and each sample had three counts for the three rows of holes. Counts of the side holes contained data for each sample along both sides of the catheter, two counts per sample. The row of holes in direct contact with the cells, bottom row, were counted per sample. Data collected from the cell counts were analyzed to test for normalcy by using the Anderson Darling equation. Parametric results from the normal distribution test were analyzed by using the Welch test with α=0.05. Utilization of the Mann-Whitney U test was done with α=0.05 for non-parametric results.

Results

Cell Counts

Images of the ventricular shunt catheter samples were taken when the catheter was still in the chamber system. The catheters were imaged to include the two rows of holes on the sides of the catheter. Data showed that the cell counts of the blood exposed sample greater than the control group (Figure 3A). Average count of the DAPI and GFAP stains for the control samples were 92.7±48.7 and 177.8±138.1 cells respectively. The blood exposed sample showed to have an average DAPI count of 475.3±342.5 and 1029.5±429.9 cell count for GFAP (Table 1). Analysis of the control and blood exposed samples showed a significant increase in cell attachment when exposed to blood (P<0.0001).

Figure 3:

Figure 3:

Average counts of cellular attachment on the surface of the catheter for samples exposed and not exposed to blood measured by total cell count (DAPI) and cell spread (GFAP). (A) 2 Rows of Holes along the Side (n=10) (B) Row of Holes in Direct Contact with the Cells (n=5) * P<0.0001

Table 1:

Table of the average cell counts with standard deviation.

DAPI GFAP
Control Side 92.7 ± 48.7 177.8 ± 138.1
Blood Side 475.3 ± 342.5 1029.5 ± 429.9
Control Bottom 98.8 ± 39.6 167.2 ± 66.9
Blood Bottom 225.4 ±189.7 504.2 ± 255.5
Total Control 94.7 ± 44.5 174.3 ± 116.5
Total Blood 392.0 ± 317.1 854.4 ± 450.7

Development of this model was also created to hold enough volume for cell culturing and break the top portion of the chamber for imaging. The pH indicator in the cell culture media offered a calorimetric indicator of cell toxicity, as was identified under a light microscope. The ventricular shunt catheter’s row of holes in direct contact with the cells (denoted “bottom” because of their orientation in the chamber) were removed from the chambers and imaged for cell counts (Figure 3B). Average cell count of the DAPI stain was 98.8±39.6 for the control sample and the blood exposed sample was 225.4±189.7 cells. For the GFAP stain the average count was 167.2±66.9 and 504.2±255.5 for the control and blood exposed sample respectively (Table 1). Comparisons of samples exposed and not exposed to blood showed a significant difference in total cell attachment on the surface of the catheter (P<0.001).

Discussion

This study serves as a preliminary investigation into the astrocytic response following BBB rupture from shunt insertion and shows a significant increase in cellular attachment when exposed to blood (P<0.0001). Rupture of the BBB causes an increase in VZ permeability similar to other chronic indwelling devices within the brain29. Using this 3D printed in vitro model, we were able to mimic breaking the BBB and subsequent astrogliosis. In a study done by Castaneyra-Ruiz, it was described that the optimal concentration of blood was 3% over a 48-hour time period with higher concentrations, 4% blood, showing significant cell death. This decrease in cells prevented any observations, at higher concentrations, past the 3-hour time point. Since our experiment ran for two weeks, a significantly longer time period, we opted to decrease our blood concentration to 1.5% in the media to prevent excessive cell death and allow for a sufficient number of cells to survive for analysis. Certainly, concentration and time-point dependencies will exist, which will be studied in future work. Additionally, the incorporation of a bioreactor-based flow system at physiologic flow and shear rates may augment the possibility for dynamic changes in blood protein adsorption.

Replication of industrial catheters using a leather punch created a rough surface similar to that of industrial made catheters. In previous work, it was shown that these imperfections cause an increase in cellular adhesion30. The addition of this rough surface may perhaps give rise to an increased opportunity for increased blood protein adsorption and/or astrocyte attachment. Silicone catheters have been known to have relatively hydrophobic properties allowing for an increase in cellular adsorption to the surface31. Along with the addition of holes creating a rough surface, the hydrophobic characteristic creates a device prone to more cellular attachment.

Choosing to limit the investigation to astrocytes alone was due to the known reactivity after exposure to blood along with its prevalent role in general shunt obstruction25,32,33. Certainly, the acute- and chronic- response to the shunt catheter is dynamic, multi-factorial, and dependent on environmental conditions. Included in this response, we must consider that the ependymal layer that makes up the ventricular wall breaks down when exposed to blood allowing the astrocytes to migrate into the ventricular space. Catheter contact with the ventricular wall also increases astrocyte density close to the interface between the wall and the shunt catheter34. Astrogliosis will occur when the cells are exposed to blood following shunt insertion and subsequent breaking of the BBB21. Within whole blood, fibronectin has been shown to stimulate the growth of cells by using RGD mechanisms35. In future work, we plan run a similar experiment utilizing ependymal cells due to their importance in allowing the activation of astrocytes due to VZ breakdown12.

Astrocytic response is likely to be due to the bodies intuitive need to repair itself following a trauma20. Data presented here indicates that the activation of astrocytes, due to blood, increases proliferation of astrocytes following their exposure due to VZ disruption causing the migration to the shunt surface20. Cell exposure to blood products to represent breaking of the BBB was done and showed an increase of cellular attachment to the surface of the catheter around the holes3638. Cellular attachment to the surface of the shunt showed an insignificant difference of DAPI and GFAP expression along the side of the catheter compared to holes on the bottom, in direct contact to cells, for the control samples (P>0.05). The difference in DAPI signal of the blood exposed sample was also insignificant as well, but GFAP expression showed a significantly higher count around the row of holes along the side of the catheter (P<0.05). One possible reason for an insignificant difference is due to the removal of the catheter from the culture. There could have been a potential ripping of cells from the surface of the catheter upon extraction of the shunt

Average total cell counts of all three rows of holes for each sample is 94.7±44.5 for the control and 392.0±317 for the blood exposed samples taken from the DAPI stain, for cell nuclei (Figure 4). A comparison of these two groups showed a significant increase in cells when exposed to blood for the two-week period (p<0.0001). From this we can determine that the blood had a negative effect on the cells causing an increase in catheter obstruction. Along the holes on the sides of each sample there was a significant increase in the number of cells when exposed to blood (p=0.0026). An increase of cells along the side indicates the migration of cells from the ventricular wall up to the side holes.

Figure 4:

Figure 4:

Average total cell count attached to the catheter surface per sample (n=15).*P<0.0001

Investigation into the astrocytic response was analyzed by staining with GFAP stains to visualize the astrocytes on the catheter due to its cytoplasm attachment property. Comparisons between the control and blood exposed samples show a significant difference in total sample GFAP expression (P <0.0001). These data suggest that there is a potential effect from blood proteins, when added into the media, enhances cell spread and/or cell reactivity. Rows of the holes on the sides of each sample showed a significant difference between the two groups (p<0.0001). This indicates that the cells expressed on the sides are migrating from the cell layer along the bottom of the well up along the catheter. Astrocyte activation occurs in response to stimuli in an effort to repair the brain via proliferation and extension of astrocyte processes39,40. Perhaps increased concentration and type of protein adsorbed to the polydimethylsiloxane shunt surface enhances the receptor-integrin interplay and increases cell attachment, not just in cell number, but in cell affinity to the surface (Figure 5). Increased GFAP expression after whole blood exposure may also be indicative of enhanced neuroinflammation, cytoskeletal changes, and/or increased cell communication.

Since GFAP stains within the cytoplasm, it allows for a single astrocyte to be stained multiple times. The software takes into account intensity and signal diameter when analyzing the cell count, but still can be added to the total count. This could be a methodological explanation for the higher expression in comparison to DAPI. When comparing the cell counts of the control and blood exposed samples of the DAPI and GFAP stains, they were analyzed separately to account for the antibody’s expression behaviors.

Blood within the chamber contained no cells that would be positively stained with GFAP, indicating that the expression is limited only to astrocytes. The use of DAPI to stain the DNA within the nucleus is not affected by the addition of blood due to the small amount of blood used along with the majority of the components of blood not containing a nucleus. Small amounts of cells within the blood that could have been pick up by the DAPI stain were filtered out by setting a specific diameter, such that the software only counts the astrocytic nuclei.

Conclusion

BBB breakdown poses increased propensity for blood to enter the ventricles which significantly increases astrocyte attachment. The development of a novel chamber system was required to replicate the insertion of a catheter directly on top of the cell layers and expose them to blood. With this system we can also take images of the samples without removing the catheter from the culture. Since we know astrocytes play a major role in shunt obstruction and failure of shunts used to treat hydrocephalus, this initial study shows the necessity of future work examining the role blood products play in the shunted pathology of hydrocephalus and pushes us to examine ways in which we can inhibit BBB permeability. Analysis of the samples showed that samples exposed to blood caused a significant increase in cell count and GFAP expression. The activation of the cells caused the increase in cell count, and the high expression of GFAP indicates a more spread-out morphology. Future work will examine the rates of shunt insertion, correlated BBB breakdown, and effects of various blood products. We plan to investigate other time points associated with blood entering the ventricular space. This would include disruption of the ventricular zone when exposed to blood for the length of an intraventricular hemorrhage and insertion of a catheter to represent a patient with posthemorrhagic hydrocephalus. Further exploration into this topic will also include an analysis of the role of ependymal cells when exposed to blood following breaking of the BBB.

Figure 1:

Figure 1:

Schematic of the chamber system used in this experiment. (A) Full Chamber System (B) Image of Catheter and Cell Orientation within the chamber with labels for the three rows of holes.

Figure 2:

Figure 2:

Diagram of the experimental timeline.

Acknowledgements

We would like to acknowledge Wayne State University for allowing us to use their facilities, for this procedure. Dr. James McAllister and Mr. Leandro Castaneyra-Ruiz for assisting with development of methodology for cell culturing. Dr. David Limbrick for help with development of investigation and conceptualization.

Funding:

Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS094570. Approximately 90% was financed with federal dollars. The content is solely the responsibility of the authors and does not necessarily represent the official view of the Hydrocephalus Association or the National Institutes of Health.

List of Abbreviations

CSF

Cerebrospinal Fluid

PHH

Posthemorrhagic Hydrocephalus

IVH

Intraventricular Hemorrhage

ICH

Intracerebral Hemorrhage

GMH

Germinal Matrix Hemorrhage

BBB

Blood Brain Barrier

NSC

Neural Stem Cells

VZ

Ventricular Zone

PBS

Phosphate Buffer Solution

VOC

Volatile Organic Compounds

AS-3

Additive Solution Three

DMEM

Dulbecco’s Modified Eagle Medium

Footnotes

Conflicts of Interest: The authors declare that they have no conflicts of interest.

Availability Statement

Raw data were generated at Wayne State University and can be made available to other qualified research scientists for appropriate applications and collaborative efforts in accordance with Wayne State University’s materials transfer guidelines as well as those set by NIH and the Hydrocephalus Association. Patentable work will be reviewed by the Wayne State Technology Transfer Office prior to data sharing, were applicable.

References

  • 1.Pople IK. Hydrocephalus and shunts: What the neurologist should know. Neurol Pract. 2002;73(1). doi: 10.1136/jnnp.73.suppl_1.i17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Corns R, Martin A. Hydrocephalus. Surgery. 2012;30(3):142–148. doi: 10.1016/j.mpsur.2011.12.010 [DOI] [Google Scholar]
  • 3.Del Bigio MR. Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev. 2010;16(1):16–22. doi: 10.1002/ddrr.94 [DOI] [PubMed] [Google Scholar]
  • 4.Rekate HL. The definition and classification of hydrocephalus: A personal recommendation to stimulate debate. Cerebrospinal Fluid Res. 2008;5:1–7. doi: 10.1186/1743-8454-5-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Leinonen V, Vanninen R, Rauramaa T. Cerebrospinal Fluid Circulation and Hydrocephalus. Vol 145. 1st ed. Elsevier B.V.; 2018. doi: 10.1016/B978-0-12-802395-2.00005-5 [DOI] [PubMed] [Google Scholar]
  • 6.Harris C, Pearson K, Hadley K, et al. Fabrication of three-dimensional hydrogel scaffolds for modeling shunt failure by tissue obstruction in hydrocephalus. Fluids Barriers CNS. 2015;12(1):1–15. doi: 10.1186/s12987-015-0023-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sarkiss CA, Sarkar R, Yong W, Lazareff JA. Time dependent pattern of cellular characteristics causing ventriculoperitoneal shunt failure in children. Clin Neurol Neurosurg. 2014;127:30–32. doi: 10.1016/j.clineuro.2014.09.029 [DOI] [PubMed] [Google Scholar]
  • 8.Drake JM, Kestle JRW, Tuli S. CSF shunts 50 years on - Past, present and future. Child’s Nerv Syst. 2000;16(10–11):800–804. doi: 10.1007/s003810000351 [DOI] [PubMed] [Google Scholar]
  • 9.Bonfield TL, Colton E, Anderson JM. Protein adsorption of biomedical polymers influences activated monocytes to produce fibroblast stimulating factors. J Biomed Mater Res. 1992;26(4):457–465. doi: 10.1002/jbm.820260404 [DOI] [PubMed] [Google Scholar]
  • 10.Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery. 1998;42(2):316–319. doi: 10.1097/00006123-199802000-00064 [DOI] [PubMed] [Google Scholar]
  • 11.Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: A review of the cellular pathology. Neurosurgery. 1998;42(2):319–326. doi: 10.1097/00006123-199802000-00064 [DOI] [PubMed] [Google Scholar]
  • 12.Castaneyra-Ruiz L, Morales DM, McAllister JP, et al. Blood exposure causes ventricular zone disruption and glial activation in vitro. J Neuropathol Exp Neurol. 2018;77(9):803–813. doi: 10.1093/jnen/nly058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gluski J, Zajciw P, Hariharan P, et al. Characterization of a multicenter pediatric-hydrocephalus shunt biobank. Fluids Barriers CNS. 2020;17(1):1–10. doi: 10.1186/s12987-020-00211-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Riva-Cambrin J, Kestle JRW, Holubkov R, et al. Risk factors for shunt malfunction in pediatric hydrocephalus: A multicenter prospective cohort study. J Neurosurg Pediatr. 2016;17(4):382–390. doi: 10.3171/2015.6.PEDS14670 [DOI] [PubMed] [Google Scholar]
  • 15.Jaeger CB, Winn SR, Tresco PA, Aebischer P. Repair of the blood-brain barrier following implantation of polymer capsules. Brain Res. 1991;551(1–2):163–170. doi: 10.1016/0006-8993(91)90929-P [DOI] [PubMed] [Google Scholar]
  • 16.Yang C, Hawkins KE, Doré S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol - Cell Physiol. 2019;316(2):C135–C153. doi: 10.1152/ajpcell.00136.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Achyuta AKH, Stephens KD, Lewis HGP, Murthy SK. Mitigation of reactive human cell adhesion on poly(dimethylsiloxane) by immobilized trypsin. Langmuir. 2010;26(6):4160–4167. doi: 10.1021/la903441u [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Strahle J, Garton HJL, Maher CO, Muraszko KM, Keep RF, Xi G. Mechanisms of Hydrocephalus After Neonatal and Adult Intraventricular Hemorrhage. Transl Stroke Res. 2012;3(SUPPL. 1):25–38. doi: 10.1007/s12975-012-0182-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.McAllister JP, Guerra MM, Ruiz LC, et al. Ventricular zone disruption in human neonates with intraventricular hemorrhage. J Neuropathol Exp Neurol. 2017;76(5):358–375. doi: 10.1093/jnen/nlx017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Harris C, Pearson K, Hadley K, et al. Fabrication of three-dimensional hydrogel scaffolds for modeling shunt failure by tissue obstruction in hydrocephalus. Fluids Barriers CNS. 2015;12(1):1–15. doi: 10.1186/s12987-015-0023-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ding Y, Zhang T, Wu G, et al. Astrogliosis inhibition attenuates hydrocephalus by increasing cerebrospinal fluid reabsorption through the glymphatic system after germinal matrix hemorrhage. Exp Neurol. 2019;320(June):113003. doi: 10.1016/j.expneurol.2019.113003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Klebe D, McBride D, Krafft PR, Flores JJ, Tang J, Zhang JH. Posthemorrhagic hydrocephalus development after germinal matrix hemorrhage: Established mechanisms and proposed pathways. J Neurosci Res. 2020;98(1):105–120. doi: 10.1002/jnr.24394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brydon HL, Keir G, Thompson EJ, Bayston R, Hayward R, Harkness W. Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry. 1998;64(5):643–647. doi: 10.1136/jnnp.64.5.643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Roales-Buján R, Páez P, Guerra M, et al. Astrocytes acquire morphological and functional characteristics of ependymal cells following disruption of ependyma in hydrocephalus. Acta Neuropathol. 2012;124(4):531–546. doi: 10.1007/s00401-012-0992-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cozzens JW, Chandler JP. Increased risk of distal ventriculoperitoneal shunt obstruction associated with slit valves or distal slits in the peritoneal catheter. J Neurosurg. 1997;87(5):682–686. doi: 10.3171/jns.1997.87.5.0682 [DOI] [PubMed] [Google Scholar]
  • 26.Jiménez AJ, Domínguez-Pinos MD, Guerra MM, Fernández-Llebrez P, Pérez-Fígares JM. Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue Barriers. 2014;2(3):1–14. doi: 10.4161/tisb.28426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Heaton A, Keegan T, Holme S. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol. 1989;71(1):131–136. doi: 10.1111/j.1365-2141.1989.tb06286.x [DOI] [PubMed] [Google Scholar]
  • 28.Castaneyra-Ruiz L, McAllister JP, Morales DM, Brody SL, Isaacs AM, Limbrick DD. Preterm intraventricular hemorrhage in vitro: Modeling the cytopathology of the ventricular zone. Fluids Barriers CNS. 2020;17(1):1–11. doi: 10.1186/s12987-020-00210-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Skousen JL, Bridge MJ, Tresco PA. A strategy to passively reduce neuroinflammation surrounding devices implanted chronically in brain tissue by manipulating device surface permeability. Biomaterials. 2015;36:33–43. doi: 10.1016/j.biomaterials.2014.08.039 [DOI] [PubMed] [Google Scholar]
  • 30.Harris CA, McAllister JP. Does drainage hole size influence adhesion on ventricular catheters? Child’s Nerv Syst. 2011;27(8):1221–1232. doi: 10.1007/s00381-011-1430-0 [DOI] [PubMed] [Google Scholar]
  • 31.Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100. doi: 10.1016/j.smim.2007.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chittiboina P, Pasieka H, Sonig A, et al. Posthemorrhagic hydrocephalus and shunts: What are the predictors of multiple revision surgeries? Clinical article. J Neurosurg Pediatr. 2013;11(1):37–42. doi: 10.3171/2012.8.PEDS11296 [DOI] [PubMed] [Google Scholar]
  • 33.Bir SC, Konar S, Maiti TK, Kalakoti P, Bollam P, Nanda A. Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus. Child’s Nerv Syst. 2016;32(8):1405–1414. doi: 10.1007/s00381-016-3090-6 [DOI] [PubMed] [Google Scholar]
  • 34.Del Bigio MR, Fedoroff S. Short‐term response of brain tissue to cerebrospinal fluid shunts in vivo and in vitro. J Biomed Mater Res. 1992;26(8):979–987. doi: 10.1002/jbm.820260802 [DOI] [PubMed] [Google Scholar]
  • 35.Sottile J, Hocking DC, Langenbach KJ. Fibronectin polymerization stimulates cell growth by RGD-dependent and -independent mechanisms. J Cell Sci. 2000;113(23):4287–4299. doi: 10.1242/jcs.113.23.4287 [DOI] [PubMed] [Google Scholar]
  • 36.Collins P, Hockley AD, Woollam DHM. Surface ultrastructure of tissues occluding ventricular catheters. J Neurosurg. 1978;48(4):609–613. doi: 10.3171/jns.1978.48.4.0609 [DOI] [PubMed] [Google Scholar]
  • 37.Beer R, Pfausler B, Schmutzhard E. Management of nosocomial external ventricular drain-related ventriculomeningitis. Neurocrit Care. 2009;10(3):363–367. doi: 10.1007/s12028-008-9155-y [DOI] [PubMed] [Google Scholar]
  • 38.Lewis A, Taylor Kimberly W. Prediction of ventriculoperitoneal shunt placement based on type of failure during external ventricular drain wean. Clin Neurol Neurosurg. 2014;125:109–113. doi: 10.1016/j.clineuro.2014.07.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Schiweck J, Eickholt BJ, Murk K. Important shapeshifter: Mechanisms allowing astrocytes to respond to the changing nervous system during development, injury and disease. Front Cell Neurosci. 2018;12(August):1–17. doi: 10.3389/fncel.2018.00261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sterpka A, Yang J, Strobel M, Zhou Y, Pauplis C, Chen X. Diverged morphology changes of astrocytic and neuronal primary cilia under reactive insults. Mol Brain. 2020;13(1):1–16. doi: 10.1186/s13041-020-00571-y [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Raw data were generated at Wayne State University and can be made available to other qualified research scientists for appropriate applications and collaborative efforts in accordance with Wayne State University’s materials transfer guidelines as well as those set by NIH and the Hydrocephalus Association. Patentable work will be reviewed by the Wayne State Technology Transfer Office prior to data sharing, were applicable.

RESOURCES